Author | Andrei Gafita, MD | OncLive

Author | Andrei Gafita, MD

Articles

Dr. Gafita on Prognostic Models for Treatment With 177Lu-PSMA-617 in mCRPC

August 05, 2020

Video

Andrei Gafita, MD, discusses key takeaways from a retrospective analysis evaluating lutetium-177 PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Dr. Gafita on the Opportunity for 177Lu-PSMA-617 in mCRPC

July 28, 2020

Video

Andrei Gafita, MD, discusses available therapies for men with advanced castration-resistant prostate cancer.

Dr. Gafita on the Rationale to Evaluate 177Lu-PSMA-617 in mCRPC

July 17, 2020

Video

Andrei Gafita, MD, discusses the rationale to evaluate lutetium-177 PSMA-617 in metastatic castration-resistant prostate cancer.

Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC

June 17, 2020

Video

Andrei Gafita, MD, discusses sequencing lutetium-177 PSMA-617 in metastatic castration-resistant prostate cancer.

x